Medicines Co. Stock
-
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
Cons
Performance of Medicines Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicines Co. | - | - | - | - | - | - | - |
| Opko Health Inc. | 8.490% | 6.533% | -16.535% | -5.069% | -2.770% | -31.833% | -64.819% |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | 1.160% | 1.149% | 10.692% | -9.278% | -10.204% | -33.333% | -21.429% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -7.563% | 0.917% | -43.005% | -54.918% |
Comments
News
A BeOne Founder Sold $34.6 Million in Stock but Keeps a Massive Position
John Oyler, the chief executive officer of BeOne Medicines AG (NASDAQ:ONC), sold 109,713 American Depositary Shares in transactions executed on July 20, 2026, and July 21, 2026, according to an SEC
House of Hope in Bamako Continues to Provide Vital Support for Vulnerable Women in Mali in 2026
BUDAPEST, HUNGARY / ACCESS Newswire / July 22, 2026 / The Gedeon Richter House of Hope centre in Bamako, Mali, continued to provide comprehensive support for vulnerable women and girls
This Stock Has Skyrocketed 125% in 2026 -- and Billionaire Stanley Druckenmiller Is Loading Up on It
Revolution Medicines (NASDAQ: RVMD) aims to replace chemotherapy for some of the most aggressive cancers with its targeted treatments. It directly targets the RAS protein -- which feeds the growth


